Results 31 to 40 of about 1,496 (157)

Toxemia in Human Naturally Acquired Botulism

open access: yesToxins, 2020
Human botulism is a severe disease characterized by flaccid paralysis and inhibition of certain gland secretions, notably salivary secretions, caused by inhibition of neurotransmitter release.
Christine Rasetti-Escargueil   +2 more
doaj   +1 more source

Wound botulism in an intravenous drug user

open access: yesInternational Journal of Infectious Diseases
Zunaid Ahmed, Willem Izak Visser
doaj   +3 more sources

Equine botulism. [PDF]

open access: yesEquine Vet J
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Slavik K, Whitlock R, Johnson A.
europepmc   +2 more sources

Microbial communities and functional diversity in seafood

open access: yesJSFA reports, Volume 6, Issue 10, Page 392-421, October 2026.
Abstract Functional diversity encompasses ecosystem processes that enhance adaptability to environmental change. This study explores the diversity of microorganisms associated with seafood. In this paper, we present our knowledge of microbial diversity in relation to seafood.
Christian Larbi Ayisi   +3 more
wiley   +1 more source

Survival of Listeria monocytogenes and Salmonella Typhimurium in Pepperoni With Reduced Salt and Sodium Nitrite Levels, and Sublethal Thermal Treatments

open access: yesJournal of Food Safety, Volume 46, Issue 5, October 2026.
Reduced salt and sodium nitrite pepperoni formulations were challenged with Listeria monocytogenes and Salmonella Typhimurium and subjected to fermentation followed by a postfermentation thermal treatment and drying. Enhanced thermal treatments improved pathogen reductions across formulations, supporting the importance of validated multihurdle ...
Shannon Heapes   +6 more
wiley   +1 more source

Botulism and Bioterrorism: How Serious is This Problem?

open access: yesActa Medica, 2005
Botulism is a potentially lethal disease caused by one of seven homologous neurotoxic proteins usually produced by the bacterium, Clostridium botulinum. This neuromuscular disorder occurs through an exquisite series of molecular events, ultimately ending
Jiří Patočka   +2 more
doaj   +1 more source

Pragmatic Phenotype–Electrophysiology–Genomics Integration in Pediatric Congenital Myasthenic Syndromes: Insights From 36 Patients in a Single‐Center Study in China

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
In 36 Chinese pediatric CMS patients, integrated phenotype, RNS, and genomic assessment revealed marked genetic heterogeneity across 17 CMS‐associated genes and frequent VUS‐related uncertainty. Genotype‐informed therapy improved MG‐ADL scores, while CHAT‐CMS identified a high‐risk subgroup for early respiratory failure and mortality.
Liya Cui   +18 more
wiley   +1 more source

Botulismo de origem alimentar Foodbourne botulism

open access: yesCiência Rural, 2008
O botulismo alimentar ocorre pela ingestão de toxinas pré-formadas pelo Clostridium botulinum, consideradas as mais potentes dentre as toxinas conhecidas.
Natacha Deboni Cereser   +4 more
doaj   +1 more source

Botulinum Neurotoxins (BoNTs) and Their Biological, Pharmacological, and Toxicological Issues: A Scoping Review

open access: yesApplied Sciences, 2021
Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini   +10 more
doaj   +1 more source

Feasibility and Safety of Washed Microbiota Transplantation as Salvage Therapy for Refractory Non‐CDI Gut Pathogens in Critically Ill Patients

open access: yesMicrobial Biotechnology, Volume 19, Issue 8, August 2026.
Ten patients with definite gut infection evidence beyond CDI underwent 29 WMT infusions. 50% (5/10) of patients obtained clinical cure after WMT. 20% (2/10) of patients achieved clinical improvement and 30% (3/10) showed no response 7 days after WMT. One transient WMT‐related fever occurred (1/29, 3.45%).
Jie Xu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy